Day: September 29, 2021

FDA Sets PDUFA Target Action Date of May 29, 2022 for the New Drug Application and July 29, 2022 for the Biologics License Application On Track for MAA Submission in the Fourth Quarter of this Year PHILADELPHIA, Sept. 29, 2021 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq: FOLD) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) for cipaglucosidase alfa and the New Drug Application (NDA) for miglustat for AT-GAA, the Company’s investigational two-component therapy for the treatment of Pompe disease. Pompe disease is a rare genetic disease that causes premature death and has a debilitating effect on people’s lives. The U.S. represents the single largest geography for Amicus to positively impact the lives of people with Pompe disease. The FDA has set a...

WALTHAM, Mass., Sept. 29, 2021 (GLOBE NEWSWIRE) — Adagio Therapeutics, Inc., (Nasdaq: ADGI), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential, today announced that management will participate in a fireside chat during the Guggenheim 2nd Annual Vaccines & Infectious Day Conference on Wednesday, Oct. 6, 2021 at 1:30 p.m. ET. The live webcast will be available in the investor section of the company’s website at investors.adagiotx.com. The webcast will be archived for 60 days following the presentation. About Adagio TherapeuticsAdagio (Nasdaq: ADGI) is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of antibody-based solutions for infectious...

TORONTO, Sept. 29, 2021 (GLOBE NEWSWIRE) — Kirkland Lake Gold Ltd. (“Kirkland Lake Gold” or the “Company”) (TSX:KL) (NYSE:KL) (ASX:KLA) today reported that, following the announcement of a merger of equals agreement with Agnico Eagle Mines Limited, the Company has suspended its automatic share purchase plan (“ASPP”) effective today, September 28, 2021. The ASPP was launched on June 21, 2021 in connection with the Company’s normal course issuer bid (“NCIB”) to allow for share purchases that would not be subject to black-out periods or other restrictions. The current NCIB remains in effect on the same terms and conditions as previously disclosed. Under the current NCIB, the Company can purchase up to 26,694,051 common shares until the expiry of the NCIB on June 8, 2022. A total of 3,392,100 common shares have been repurchased to...

Amsterdam, the Netherlands – 29 September 2021 – Intertrust N.V. (“Intertrust” or “the Company”) [Euronext: INTER], a global leader in providing tech-enabled fund and corporate solutions, has taken note of the statement made by Harbor Spring Capital on 29 September 2021. As stated in the announcement on 27 September 2021, the Management Board and the Supervisory Board are of the view that the Company’s current market valuation does not reflect its intrinsic value and continue to actively explore options to deliver shareholder value. Accordingly, the Company announced a programme to repurchase ordinary shares in its capital for a total aggregate consideration of EUR 100 million. Intertrust continues to maintain an open dialogue with investors and will provide a comprehensive update on its strategy at its capital markets day on 23 November...

Temecula, CA, Sept. 29, 2021 (GLOBE NEWSWIRE) — Global Warming Solutions, Inc., (OTC: GWSO), a worldwide developer of technologies that help mitigate global warming and its effects on the planet announces a reduction of 2,655,885 shares of its outstanding common stock. “We are pleased to announce that we have successfully reduced the outstanding shares by another 2.655 million, that were previously issued and outstanding. We are continuously putting the interest of our shareholders first.” – Michael Pollastro, President of GWSO. “There is a profound and seemingly long-lasting shift to sustainability, with the U.S., China and Europe all on a green path. And U.S. cities and counties more than tripled the size of their renewable energy deals from 2015 to 2020, according to the American Cities Climate Challenge. Moreover, the...

Allot replaces existing solution with its SmartTraffic QoE solution to improve Quality of Service for ISPs under Asahi Net and their customers. Hod Hasharon, Israel, Sept. 29, 2021 (GLOBE NEWSWIRE) — Allot Ltd. (NASDAQ: ALLT) (TASE: ALLT), a leading global provider of innovative network intelligence and security-as-a-service (SECaaS) solutions for communication service providers (CSPs) and enterprises, today announced that Asahi Net, a broadband provider in Japan, has launched Allot’s SmartTraffic QoE solution. SmartTraffic QoE provides comprehensive network traffic analytics as well as flexible, granular and precise real-time traffic management, which will improve network Quality of Experience (QoE) for Asahi Net’s VNOs and their broadband customers.   With the deployment of SmartTraffic QoE, Allot has replaced the incumbent solution,...